South Florida Family Health and Research Centers Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2011
NCT01514513
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

South Florida Family Health and Research Centers

Active Ingredients

Drugs in Phase 3 Trials (1)

benzyl alcohol (ulesfia) (1 trial)

Drugs in Other Trials (1)

permethrin (nix) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lice Infestations (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2